Current Issue
The July 2024 issue (43:5) features the special section ‘In memory of an activist: Contributions celebrating the life of Jude Byrne’. This includes an editorial and papers that discuss: enriching qualitative alcohol and other drug research by engaging lived experience peer researchers in a dual-interview approach; engaging families and parent advocates in research on substance use and drug policy reform; towards structural indicators of community-based participatory action research; the gendered violence of injecting-related stigma among relatively affluent, suburban women who inject drugs; experiences of stigma and subsequent reduced access to health care among women who inject drugs; factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales; increasing linkage to hepatitis C care following trauma-informed rehabilitation; information acquisition and dissemination among a sample of people who inject drugs in Australia; and a reflection on improving the lives of people who use and inject drugs.
Other research in this issue covers a range of topics, with research from Australia on using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment; where high-risk drinking occasions occur more often; the absence of mandatory pregnancy warning labels in online alcohol purchasing contexts; prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse; alcohol screening in 22 Australian Aboriginal Community Controlled Health Organisations; micro-elimination of chronic hepatitis C virus in mental health settings; the ‘missing’ in the ‘endgame’ of hepatitis C elimination; stigma, and factors associated with experiencing stigma, while visiting health-care services among samples of people who use illegal drugs; a qualitative investigation of the factors influencing Australian health-care practitioners' delivery of medicinal cannabis; stocking and supplying naloxone; and the reflections of health service providers on implementing contingency management for methamphetamine use disorder.
Research from overseas includes a longitudinal investigation of New Zealand adults on psychological predictors of vaping uptake among non-smokers; opioid use, prescribing and fatal overdose patterns among racial/ethnic minorities in the United States; a population study in Great Britain on trends in purchasing cross-border, illicit and home-brewed alcohol; pharmacological treatments for alcohol dependence; effectiveness of web-based personalised feedback interventions for reducing alcohol consumption among university students; understanding the alcohol treatment landscape and needs among unstably housed people who use alcohol; and cannabidiol use in France in 2022.
This issue also features an obituary in memory of Kyp Kypri.
Cannabis legalisation and its impact on access, use and public perceptions
Follow Drug and Alcohol Review on Twitter
What's new on Early View?
The latest COVID-19 research is available online.
Editorial
The market matters: Shifting the minimum unit price
Nicholas Taylor, Michael Livingston
13 May 2024 | DOI: https://doi.org/10.1111/dar.13866
Comprehensive Reviews
Digital alcohol marketing and gender: A narrative synthesis
Antonia C. Lyons, Kate Kersey, Carol Emslie, Elena Dimova, Annamae Burrows
22 April 2024 | DOI: https://doi.org/10.1111/dar.13849
Self-change from problems with alcohol and drugs: A scoping review of the literature since 2010
Florian De Meyer, Nellie Bencherif, Clara De Ruysscher, Lou Lippens, Wouter Vanderplasschen
19 March 2024 | DOI: https://doi.org/10.1111/dar.13834
Reviews
Overdose prevention centres as spaces of safety, trust and inclusion: A causal pathway based on a realist review
Alex Stevens, Jolie R. Keemink, Sam Shirley-Beavan, Zarnie Khadjesari, Adelina Artenie, Peter Vickerman, Mat Southwell, Gillian W. Shorter
5 August 2024 | DOI: https://doi.org/10.1111/dar.13908
The impacts of alcohol marketing and advertising, and the alcohol industry's views on marketing regulations: Systematic reviews of systematic reviews
Norman Giesbrecht, Emilene Reisdorfer, Kevin Shield
27 May 2024 | DOI: https://doi.org/10.1111/dar.13881
Original Papers
An empirically based typology of temporary alcohol abstinence challenge participants using latent class analysis
Nathalie Kools, Andrea D. Rozema, Jeroen K. Vermunt, Rob H. L. M. Bovens, Dike van de Mheen, Jolanda J. P. Mathijssen
18 August 2024 | DOI: https://doi.org/10.1111/dar.13924
Screening and early intervention for substance use during pregnancy: A retrospective case note review of antenatal care records
Matthew W. R. Stevens, Megan Cooper, Lynette Cusack, Robert L. Ali, Chris Holmwood, Annette L. Briley
13 August 2024 | DOI: https://doi.org/10.1111/dar.13927
Identifying and responding to fetal alcohol spectrum disorder in child and family health: Lessons from an exploratory mixed methods study
Susan Evans, Barbara R. Lucas, Lauren Ann Monds, Mark Montebello
13 August 2024 | DOI: https://doi.org/10.1111/dar.13917
Substance use among trans and gender diverse young people in Australia: Patterns, correlates and motivations
Sasha Bailey, Ashleigh Lin, Angus Cook, Sam Winter, Vanessa Watson, Dani Wright-Toussaint, Emma L. Barrett, Nicola Newton, Yael Perry, Lucinda Grummitt, Penelope Strauss
11 August 2024 | DOI: https://doi.org/10.1111/dar.13915
Trends in toxicological findings in unintentional opioid or stimulant toxicity deaths in Québec, Canada, 2012–2021: Has Québec entered a new era of drug-related deaths?
Uyen Do, Paul-André Perron, Julie Bruneau, Sarah Larney
6 August 2024 | DOI: https://doi.org/10.1111/dar.13918
The associations of supervised consumption services with the rates of opioid-related mortality and morbidity outcomes at the public health unit level in Ontario (Canada): A controlled interrupted time-series analysis
Tessa Robinson, Forough Farrokhyar, Benedikt Fischer
5 August 2024 | DOI: https://doi.org/10.1111/dar.13921
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)
Paul J. Clark, Patricia C. Valery, Simone I. Strasser, Martin Weltman, Alex Thompson, Miriam T. Levy, Barbara Leggett, Amany Zekry, Julian Rong, Marie Sinclair, Jacob George, William Sievert, Gerry MacQuillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Wendy Cheng, Stuart K. Roberts
2 August 2024 | DOI: https://doi.org/10.1111/dar.13914
Police-issued barring notices in Western Australia: An analysis of the type, seriousness and trajectory of associated offences
Clare Farmer, Nicholas Taylor, Ryan Baldwin, Peter G. Miller
30 July 2024 | DOI: https://doi.org/10.1111/dar.13916
No- and low-alcohol beer and the sponsorship of sport in Australia: An audit of sponsorship partnerships and analysis of marketing tactics
Mia Miller, Cassandra C. J. Wright
29 July 2024 | DOI: https://doi.org/10.1111/dar.13912
A 3-year retrospective review of hospital admissions involving opioid toxicity in South Australia
Maria Sarantou, Anne L. J. Burke, Tim Semple, Jacinta L. Johnson
29 July 2024 | DOI: https://doi.org/10.1111/dar.13913
Consumption of alcohol-free and alcoholic beverages among Dutch university students: Substitution or addition?
Martine M. Groefsema, Kirsten J. M. van Hooijdonk, Carmen V. Voogt, Hanneke Hendriks, Jacqueline M. Vink
26 July 2024 | DOI: https://doi.org/10.1111/dar.13905
Patterns of substance use recovery following residential treatment: A repeated measures latent profile analysis
Laura D. Robinson, Tayla J. Degan, Frank P. Deane, Peter J. Kelly
23 July 2024 | DOI: https://doi.org/10.1111/dar.13904
Countering stereotypes: Exploring the characteristics of Aboriginal Australians who do not drink alcohol in a community representative sample
James H. Conigrave, Scott Wilson, Katherine M. Conigrave, Jimmy Perry, Noel Hayman, Tanya N. Chikritzhs, Dan Wilson, Catherine Zheng, Teagan J. Weatherall, K. S. Kylie Lee
23 July 2024 | DOI: https://doi.org/10.1111/dar.13907
Estimating the alcohol-related burden of child maltreatment among Māori in Aotearoa, New Zealand
Taisia Huckle, Helen Moewaka Barnes, Jose S. Romeo
21 July 2024 | DOI: https://doi.org/10.1111/dar.13906
Alcohol control policy and alcohol-attributable disease burden in Finland and the Baltic countries: A longitudinal study 1995–2019
Anastasia Månsson, Lode van der Velde, Thomas Karlsson, Lauri Beekmann, Elsa Jonsson Stenberg, Juanita Haagsma, Giulio Castelpietra, Emilie E. Agardh, Peter Allebeck
15 July 2024 | DOI: https://doi.org/10.1111/dar.13901
Young people's experiences of addiction to nicotine vaping products: A qualitative analysis from Aotearoa New Zealand
Anna Graham-DeMello, Olivia Sloan, Katie Frost, Janet Hoek
15 July 2024 | DOI: https://doi.org/10.1111/dar.13902
Accessing supports due to others' harmful drinking
Jade Rintala, Koen Smit, Robin Room, Heng Jiang, Anne-Marie Laslett
15 July 2024 | DOI: https://doi.org/10.1111/dar.13898
Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney
Kate Hocknull, Brennan Geiger, Mark Bartlett, Samantha Colledge-Frisby, Fiona Shand, Carolyn A. Day, Marianne Jauncey, Amanda Roxburgh
9 July 2024 | DOI: https://doi.org/10.1111/dar.13900
Harm from others' drinking among young adults in Taiwan: Predictors and deteriorating quality of life
Ren-Hao Chen, Hsing-Yi Chang, Yi-Tien Hsu, Wei J. Chen, Chuan-Yu Chen
9 July 2024 | DOI: https://doi.org/10.1111/dar.13903
The health effects of non-prescribed anabolic–androgenic steroid use: Findings from The Performance and image-enhancing drugs UseRS' Health (PUSH) audit
Matthew Dunn, Joshua Dawe, Beng Eu, Kevin Lee, Timothy Piatkowski, Mark Stoové
7 July 2024 | DOI: https://doi.org/10.1111/dar.13899
Perceived barriers to help-seeking for people who use crystal methamphetamine: Perspectives of people with lived experience, family members and health workers
Steph Kershaw, Matthew Sunderland, Anna Grager, Louise Birrell, Hannah Deen, Nicola C. Newton, Lexine A. Stapinski, Katrina E. Champion, Frances Kay-Lambkin, Maree Teesson, Cath Chapman
4 July 2024 | DOI: https://doi.org/10.1111/dar.13897
Assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents
Pooja Shakya, Jaswant Jangra, Ravindra Rao, Ashwani Kumar Mishra, Roshan Bhad
17 June 2024 | DOI: https://doi.org/10.1111/dar.13890
Through the looking glass: An alcohol advertisement every 3 minutes
Brienna N. Rutherford, Janni Leung, Daniel Stjepanović, Gary C. K. Chan
6 June 2024 | DOI: https://doi.org/10.1111/dar.13886
Client and stakeholder perceptions of a novel, nurse practitioner-led alcohol and other drug ambulatory withdrawal service
Adam Searby, Dianna Burr, Carol Reid, Darren Smyth, Sean Hynes, Mary Fenech, Katharina Merollini, Jeanine Young
3 June 2024 | DOI: https://doi.org/10.1111/dar.13870
Understanding cultural inclusion in alcohol and other drug services in New South Wales, Australia and assessing the acceptability of a cultural inclusion audit
Robyn Horwitz, Loren Brener, Sujith Kumar Prankumar, Tata de Jesus, Alison Jaworski, Ahmad Jadran, Joanne Bryant
2 June 2024 | DOI: https://doi.org/10.1111/dar.13883
‘We didn't cause the opioid epidemic’: The experiences of Australians prescribed opioids for chronic non-cancer pain at a time of increasing restrictions
Ria E. Hopkins, Gabrielle Campbell, Louisa Degenhardt, Natasa Gisev
27 May 2024 | DOI: https://doi.org/10.1111/dar.13879
Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post-legalisation
Erik Loewen Friesen, Lauren Konikoff, Sarah Dickson, Daniel Thomas Myran
27 May 2024 | DOI: https://doi.org/10.1111/dar.13869
Evaluation of the Fetal Alcohol Spectrum Disorder Hub Australia website
Melissa Mei Yin Cheung, Heather Jones, Natalie Eastwell, Tina Zhang, Kate Harford, Carol Bower, Elizabeth J. Elliott
27 May 2024 | DOI: https://doi.org/10.1111/dar.13878
E-cigarette use in pregnancy in Australia: A cross-sectional survey of public antenatal clinic attendees
Alice Rice, Melanie Kingsland, Emma Doherty, Milly Licata, Belinda Tully, John Wiggers, Luke Wolfenden, Michelle Foster, Christophe Lecathelinais, Justine Daly
23 May 2024 | DOI: https://doi.org/10.1111/dar.13864
Concurrent decline in teenage fertility rate and binge drinking? An observational study across 45 nations
Torleif Halkjelsvik, Vegard Fykse Skirbekk
21 May 2024 | DOI: https://doi.org/10.1111/dar.13867
Factors associated with very high-risk drinking in the Australian general population: How do men and women compare?
Victoria Kostadinov, Billie Bonevski, Nathan J. Harrison, Jacquie Bowden
20 May 2024 | DOI: https://doi.org/10.1111/dar.13865
The impact of the COVID-19 pandemic on calls to an alcohol and drug helpline in Victoria, Australia, for alcohol, methamphetamine and cannabis use concerns
Annette Peart, Jasmin Grigg, Christopher J. Greenwood, Jessica J. Killian, Rowan P. Ogeil, Dan I. Lubman
15 May 2024 | DOI: https://doi.org/10.1111/dar.13868
Determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada
Iuliia Makarenko, Nanor Minoyan, Stine Bordier Høj, Sasha Udhesister, Valérie Martel-Laferrière, Didier Jutras-Aswad, Sarah Larney, Julie Bruneau
13 May 2024 | DOI: https://doi.org/10.1111/dar.13862
Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes
Loren Brener, Theresa Caruana, Elena Cama, Candice Gilford, Sione Crawford, Thomas Capell-Hattam, Courtney von Hippel
2 May 2024 | DOI: https://doi.org/10.1111/dar.13861
‘Insulin is super dangerous if you don't know what you're doing’: Situating the risks of insulin within the image and performance enhancing drug community
Timothy Piatkowski, Luke Thomas Joseph Cox
25 April 2024 | DOI: https://doi.org/10.1111/dar.13857
Brief Reports
Exposure to parental problem drinking during adolescence and symptoms of depression and anxiety in young adulthood: A Swedish national cohort study
Sara Brolin Låftman, Viveca Östberg, Joakim Wahlström, Mats Ramstedt, Jonas Raninen
19 July 2024 | DOI: https://doi.org/10.1111/dar.13910
Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland
Pieter Baker, Becky L. Genberg, Jacquie Astemborski, Shruti H. Mehta, Gregory D. Kirk, Javier Cepeda
1 July 2024 | DOI: https://doi.org/10.1111/dar.13893
Who is being targeted by alcohol social media marketing? A study of Chinese young adults in Hong Kong
Rufina H. W. Chan, Dong Dong, Jiazhou Yu, Jean H. Kim
1 July 2024 | DOI: https://doi.org/10.1111/dar.13892
Party and play: Associations between US male sex workers' internet advertising characteristics and advertising chemsex to prospective clients
Kristopher J. Jackson
1 July 2024 | DOI: https://doi.org/10.1111/dar.13896
Rotation from methadone to buprenorphine using a micro-dosing regime in patients with opioid use disorder and serious mental illness: A case series
Vivian C. Praeger, Matthew Y. Frei, Dan Pham, Adrian J. Praeger, Dan I. Lubman, Shalini Arunogiri
19 June 2024 | DOI: https://doi.org/10.1111/dar.13885
Characterising individuals with a substance use disorder accessing hospital-based addiction care: Preliminary description of the outcomes for patients accessing addiction care prospective cohort study
Hannah James, Jeffrey Morgan, Seonaid Nolan
12 June 2024 | DOI: https://doi.org/10.1111/dar.13888
Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
Jenna Langlois, Nadia Fairbairn, Didier Jutras-Aswad, Bernard Le Foll, Ron Lim, M. Eugenia Socías
9 May 2024 | DOI: https://doi.org/10.1111/dar.13863
Case Series
Brain and body disconnect: A retrospective case series of subacute combined degeneration of the spinal cord from chronic nitrous oxide use in Perth, Western Australia
Jessamine Soderstrom, Jodie Grigg, Owen McWilliam, Daniel Fatovich
13 May 2024 | DOI: https://doi.org/10.1111/dar.13858
Case Reports
The role of on-site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need
Robert Page, Marianne Jauncey, Jonathan Brett, Will Wood, Amanda Roxburgh
19 July 2024 | DOI: https://doi.org/10.1111/dar.13909
A case of severe and prolonged γ-hydroxybutyrate (GHB) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper
Rachit Gupta, Greta Moon, Yvonne Bonomo, Adam Pastor
17 July 2024 | DOI: https://doi.org/10.1111/dar.13911
Management of loperamide-related opioid use disorder with buprenorphine within an Australian context: A case report
Andrew Dunn, Nicholas Wu, Frank Cordaro
9 May 2024 | DOI: https://doi.org/10.1111/dar.13860
Commentaries
Re-examining mandatory drug testing in Australian prisons
Jocelyn Chan, Mark Stoové, Jon Cook, Thileepan Naren
7 July 2024 | DOI: https://doi.org/10.1111/dar.13894
COVID-19 as a catalyst for alcohol policy change: A case study of the Gove Peninsula
Sarah Clifford, Ian Crundall
2 July 2024 | DOI: https://doi.org/10.1111/dar.13895
How can agent-based modelling provide new insights into the impact of minimum unit pricing in Scotland?
Jennifer Boyd, John Holmes, Naomi Gibbs, Charlotte Buckley, Robin Purshouse, Petra Meier
5 June 2024 | DOI: https://doi.org/10.1111/dar.13880
Co-creating and implementing a novel pre-conference event to promote equity and inclusivity among academic researchers and people who use drugs
M. J. Stowe, Louise Hansford, Rachel Halford, Jason Wallace, Lise Lafferty
27 May 2024 | DOI: https://doi.org/10.1111/dar.13882
Public health efforts to prevent expansion of alcohol retail availability in neighbourhoods with factors associated with high rates of alcohol-related harms: A case report
Melissa Hutchinson, Alexandra Swirski, Norman Giesbrecht
29 April 2024 | DOI: https://doi.org/10.1111/dar.13859
Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, Australia
Sara Farnbach, Catherine Foley, Peter Gates, Alison Seccull, Alexandra Henderson, Andrea Zocco, Michael Farrell, Anthony Shakeshaft
17 April 2024 | DOI: https://doi.org/10.1111/dar.13843
Letters to the Editor
Trends in substance use disorder mortality in the United States and worldwide, 1990–2021
Abdul Mannan Khan Minhas, Salim S. Virani, Dmitry Abramov
2 August 2024 | DOI: https://doi.org/10.1111/dar.13919
Emergence of deaths due to nitazene toxicity in Australia
Shane Darke, Johan Duflou, Michael Farrell, Julia Lappin, Amy Peacock
11 August 2024 | DOI: https://doi.org/10.1111/dar.13920
Clinical effectiveness of pharmacist administration of long-acting injectable buprenorphine: Findings from the EPIC-MATOD study
Elizabeth Grist, Ali Cheetham, John Jackson, Pene Wood, Sarah Lord, Angelo Pricolo, Ferghal Armstrong, Kirsty Morgan, Catherine Nguyen, Tom Tran, Suzanne Nielsen
3 May 2024 | DOI: https://doi.org/10.1111/dar.13856
Call for Papers
- Emergence of substances;
- Market characteristics;
- Patterns of use and broader contexts and drivers of use;
- Harms from use; and
- Individual and population-level strategies to reduce harms.
Drug and Alcohol Review - Clinician's Corner
Best way forward for services seeking to reduce substance related harm among young people
Although almost 40% of all people receiving alcohol and other drug treatment in Australia are aged less than 30 years [1], there is a substantial lack of understanding of how to support and care for young people with alcohol and other drug problems, with the number of adolescent treatment outcome studies overshadowed by those devoted to adults [2]. Few rigorous evaluations of interventions and best-practice frameworks exist, and research into how best to engage young people effectively and sensitively is limited [2]. We do know, however, that young people use drugs differently than adults and have distinct treatment requirements [3]. As such, adult alcohol and other drug interventions should not be transplanted into a youth service and expected to work [4].
Although many health services have moved to youth-centred service models to improve engagement with young people [5], implementing youth-friendly healthcare within adult-orientated health spaces remains a challenge. Hospital-based services are consistently found to be less effective in engaging young people [4] and less able to respond effectively to young people with multiple disadvantages compared to community-based interventions [6,7].
In a recent paper in Drug and Alcohol Review, ‘Time to reconsider the best practice models of substance use care for young people’ [8], my colleagues and I put forward several strategies to enhance the benefits young people can gain from engagement with AOD services. These include:
- Addressing socio-structural determinants of health;
- Youth-friendly, flexible treatment services and proactive engagement with young people;
- Improving the culture of existing mainstream services;
- Addressing service gaps and improved access to evidence-based treatment;
- Better service linkage and active collaborative care models;
- Integrated, local services and community-based approaches; and
- Preventative care and harm reduction services for young people.
Young people benefit from a flexible and holistic treatment system able to account for the unique conditions of their lives. Taking account of and adapting to young people’s realities, priorities and circumstances increases the likelihood that the engagement will be beneficial, relevant and aligned with the meaning they themselves ascribe to their drug use. This involves broadening the range of treatment options to include offerings more aligned with the priorities and goals that young people have and promoting positive community connections and opportunities for meaningful and active participation. This involves seeing young people not as passive recipients of services, but as equal partners and active participants in a change process aimed more broadly at the flourishing of young people. Such an approach has capacity to minimise substance-related health, social and economic harms for young people, their families and communities.
Dr Maja Moensted
Discipline of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
References
- Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2017-18: key findings. Australian Institute of Health and Welfare, Australian Government, Canberra; 2019. Available from: https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/aodts-2017-18-key-findings/contents/summary
- Fomiatti R, Farrugia A, Fraser S, Hocking S. Improving the effectiveness and inclusiveness of alcohol and other drug outreach models for young people: a literature review. Drugs Educ Prev Policy. 2023;30:105-14.
- Wilson M, Saggers S, Wildy H. Using narratives to understand progress in youth alcohol and other drug treatment. Qual Res J. 2013;13:114-31.
- Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J et al. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3:280-96.
- NSW Ministry of Health. Substance Use and Young People Framework. Centre for Alcohol and Other Drugs; 2014. Available from: https://www.health.nsw.gov.au/aod/professionals/Pages/substance-use-and-young-people-framework.aspx
- Gowan T, Whetstone S, Andic T. Addiction, agency, and the politics of self-control: Doing harm reduction in a heroin users’ group. Soc Sci Med. 2012;74:1251-60.
- van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Inequalities in healthcare provision for individuals with substance use disorders: perspectives from healthcare professionals and clients. J Subst Use. 2016;21:133-40.
- Moensted ML, Little S, Haber P, Day C. Time to reconsider the best practice models of substance use care for young people. Drug Alcohol Rev. 2024;43:817-22.
Full commentary is available Open Access
Moensted ML, Little S, Haber P, Day C. Time to reconsider the best practice models of substance use care for young people. Drug Alcohol Review. 2024;43:817-22. https://doi.org/10.1111/dar.13837